Extension of the mutational and clinical spectrum of <i>SOX2</i> related disorders: Description of six new cases and a novel association with suprasellar teratoma
Patrick R. Blackburn(Mayo Clinic in Arizona), Juan Carlos Zenteno(Institute of Ophthalmology), Marine I. Murphree(Mayo Clinic), Oscar F. Chacón‐Camacho(Institute of Ophthalmology), Rachael A. Vaubel(Mayo Clinic), Mariana Reyes-Rosales(Asociacion Para Evitar la Ceguera en México Hospital Dr. Luis Sánchez Bulnes), Eric W. Klee(Mayo Clinic), Jessica Nava(Institute of Ophthalmology), Cristina Villanueva‐Mendoza(Asociacion Para Evitar la Ceguera en México Hospital Dr. Luis Sánchez Bulnes), Xilma R. Ortiz‐González(Children's Hospital of Philadelphia), Pavel N. Pichurin(Mayo Clinic in Florida), Shabnam Zarei(Mayo Clinic), Graciela Arelí López-Uriarte(Universidad Autónoma de Nuevo León), Vianney Cortés‐González(Asociacion Para Evitar la Ceguera en México Hospital Dr. Luis Sánchez Bulnes), Elizabeth Bhoj(Children's Hospital of Philadelphia), Iris G. Tirado‐Torres(Universidad Autónoma de Nuevo León), Joseph E. Parisi(Mayo Clinic), Dong Li(Children's Hospital of Philadelphia), Sofía Pérez‐Solórzano(Institute of Ophthalmology)
Cited by 11
Related Papers
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
|Brain|2007|714
SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment
|Blood|2008|345
Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements
|Human Genetics|2013|242
Mutations in PDGFRB Cause Autosomal-Dominant Infantile Myofibromatosis
|The American Journal of Human Genetics|2013|206